ProKidney Corp (PROK)
followers
·
Follow
| Sector: | FINANCE |
| Industry: | GENERAL FINANCE |
| SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| CEO: | Timothy A. Bertram |
| Employees: | 3 |
| Web site: | prokidney.com |
|
2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
336-999-7028
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Please log in first to see chart